WW International opened lower at $12.86, compared with its previous close of $13.05. In the last trading session, the stock traded between $12.23 and $13.19. It showed a downward intraday trend.
An investment of $100 made 5 years ago in WW International is now worth
$ 59.59
Resulting in a loss of
$ 40.41 (40.41%)
Note: Past profits do not guarantee future returns.
Rating from 2 Analysts
Today's Change
$-0.75 (-5.71%)
Day High
$13.19
Day Low
$12.23
Day Open
$12.86
Prev Close
$13.05
Volume
1,26,411
1W Return
2.47%
1M Return
-17.24%
3M Return
-17.90%
6M Return
23.17%
1Y Return
-56.69%
Market Cap ($ Mn)
123
PE Ratio
0.15
PB Ratio
0.58
PEG Ratio
-
ROE
-
ROCE
-62.67%
EPS (TTM)
-
1 Week
2.47%
1 Month
-17.24%
3 Months
-17.90%
6 Months
23.17%
9 Months
-48.19%
WW International Q3FY26 Results: Clinical revenue up 48%, total revenue down 11%
Clinical revenue rose 48% YoY to $38 million, accounting for 25% of total revenue. Total revenue declined 11% to $152.9 million, missing consensus estimates. Adjusted EBITDA increased 21% to $51.7 million with margin expanding to 33.8%. Net income turned positive at $15.1 million compared to a loss in the prior year. FY26 revenue guidance narrowed to $625-$630 million, below analyst forecasts.
6 days agoWW International partners with Google Health to integrate Fitbit data
WW International partners with Google Health Enterprise to add wearable data to weight-management programs. Stock shares rose 11.79% to $16.80 following the partnership announcement. Morgan Stanley forecasts the global GLP-1 drug market to reach $190 billion by 2035. Eligible members gain access to Fitbit Air and Google Health Premium upon meeting activity milestones.
1mo agoWW International Q2 Results: EPS surges 98.59% YoY
WW International posted Q2 EPS of $1.41, beating estimates by 45.36% and rising 98.59% YoY. Revenue was $162.324M, beating estimates but down 14.19% YoY.
3mo agoWeight Watchers Med+ to support Medicare GLP-1 access
WW International's Weight Watchers Med+ program will support Medicare members accessing GLP-1 medications under the Medicare GLP-1 Bridge Program from July 1, 2026, to December 31, 2027. Eligible beneficiaries can purchase medications for $50 per month, with requirements including Medicare Part D and clinical eligibility. Data shows Med+ members engaging with the GLP-1 Success Program lost 29.1% more body weight at 12 months.
4mo agoWeight Watchers supports American Heart Association weight study
Weight Watchers is collaborating with the American Heart Association to enroll members in the Healthy Living BEYOND Weight Study, which focuses on the long-term health outcomes of individuals with obesity. The company's care model integrates medical and behavioral support, with data indicating that engaged members on GLP-1 medications achieve greater weight loss.
4mo agoWW International and CheqUp expand UK partnership for holistic weight health
WW International and CheqUp have expanded their partnership in the UK to offer integrated clinical and behavioural weight management. Weight Watchers members can now access CheqUp's medical weight loss programme, while CheqUp members retain full access to the Weight Watchers app and GLP-1 Companion Programme. The collaboration aims to provide a holistic approach to weight health, combining clinical oversight with behavioural science.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $506.04 | +0.32% | $1,05,708.21M | 14.01 | |
| $304.77 | -0.26% | $49,345.01M | 45.36 | |
| $292.97 | +0.93% | $23,316.90M | 10.31 | |
| $72.62 | +0.18% | $14,450.29M | 52.31 | |
| $79.43 | -1.38% | $14,087.55M | - | |
| $142.24 | -0.19% | $13,957.16M | 20.21 | |
| $22.22 | -2.29% | $11,935.03M | 11.93 | |
| $183.50 | +2.35% | $11,542.15M | 15.26 | |
| $186.19 | +0.59% | $10,862.51M | 27.11 | |
| $196.77 | +0.70% | $10,170.65M | 7.00 | |
| $103.03 | -0.49% | $8,522.13M | 34.79 | |
| $50.06 | +1.96% | $7,945.72M | 25.00 |
An investment of $100 made 5 years ago in WW International is now worth
$ 59.59
Resulting in a loss of
$ 40.41 (40.41%)
Note: Past profits do not guarantee future returns.
